STAAR Surgical vs Warby Parker
STAA and WRBY side by side, both in measuring, analyzing, and controlling instruments; photographic, medical and optical goods; watches and clocks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How STAA and WRBY compare
Warby Parker is the larger company, worth 2.5 times as much as STAAR Surgical ($3.0B against $1.2B).
On earnings, STAAR Surgical is cheaper: it trades at 351× trailing earnings, against 352× for Warby Parker.
STAAR Surgical grew revenue faster over the last twelve months (51.3% versus 11.0% for Warby Parker).
STAAR Surgical keeps more of each dollar of sales as profit, with a net margin of 1.1% compared with 0.85% at Warby Parker.
Warby Parker scores higher on the StockData Score (11 against 10 for STAAR Surgical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | STAA | WRBY |
|---|---|---|
| Size and price | ||
| Market cap | $1.2B | $3.0B |
| Share price | $24.54 | $24.61 |
| Change, 1 year | −7.7% | 22.7% |
| Change, 5 years | −78.8% | −57.1% |
| Beta (5Y) | 1.50 | 1.90 |
| Employees | 957 | 4,036 |
| StockData Score | ||
| Total score | 10 | 11 (better) |
| Valuation score | 0 | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 2 | 2 |
| Health score | 6 | 6 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 351× (better) | 352× |
| P/S | 3.6× | 3.3× (better) |
| P/B | 3.4× (better) | 7.8× |
| EV/EBITDA | 76.4× | 50.0× (better) |
| P/FCF | – | 140× |
| FCF yield | −0.55% | 0.71% (better) |
| Fair value | $15.38 | $9.45 |
| Margin of safety | −59.6% (better) | −160% |
| Growth | ||
| Revenue growth (TTM) | 51.3% (better) | 11.0% |
| Revenue growth, 5Y average | 7.9% | 17.2% (better) |
| Profitability | ||
| Gross margin | 76.6% (better) | 54.7% |
| Operating margin | 4.0% (better) | 0.17% |
| Net margin | 1.1% (better) | 0.85% |
| FCF margin | −2.0% | 2.4% (better) |
| Return on equity | 1.1% | 2.1% (better) |
| Return on invested capital | 4.2% (better) | 1.4% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 4.66 (better) | 2.27 |
| Altman Z-score | 7.82 (better) | 5.08 |
| Piotroski F-score | 2 | 5 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 110% | 101% |
| Held by insiders | – | 17.3% |
| Insider net buying, 12 months | $62.8M (better) | −$47.1M |
| Superinvestors holding | – | 2 |
| Short interest, % of float | – | 17.8% |
Go deeper
- STAA stock overview
- STAA income statement
- STAA valuation and score
- WRBY stock overview
- WRBY income statement
- WRBY valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.